生存期肾癌组织芯片

Neutrophil profiling illuminates anti-tumor antigen-presenting potency.CELL.(IF:64.5） Cancer SLC6A6-mediated taurine uptake transactivates immune checkpoint genes and induces exhaustion in CD8+ T cells.CELL.(IF:64.5） ITPRIPL1 binds CD3ε to impede T cell activation and enable tumor immune evasion.CELL.(IF:64.5） PAI-1-driven SFRP2high cancer-associated fibroblasts hijack the abscopal effect of radioimmunotherapy.CANCER CELL.(IF:48.8） Inhibiting intracellular CD28 in cancer cells enhances antitumor immunity and overcomes anti-PD-1 resistance via targeting PD-L1.CANCER CELL.(IF:48.8） Hypoxia-induced nuclear localization of ubiquinol-cytochrome-c reductase complex assembly factor 3 (UQCC3) in hepatocellular carcinoma.Signal Transduction and Targeted Therapy.(IF:40.8） GRP75 triggers white adipose tissue browning to promote cancer-associated cachexia.Signal Transduction and Targeted Therapy.(IF:40.8） Correction: CDK4/6 inhibition blocks cancer metastasis through a USP51-ZEB1-dependent deubiquitination mechanism.Signal Transduction and Targeted Therapy.(IF:40.8） Suppression of ITPKB degradation by Trim25 confers TMZ resistance in glioblastoma through ROS homeostasis.Signal Transduction and Targeted Therapy.(IF:39.3） Targeting carnitine palmitoyl transferase 1A (CPT1A) induces ferroptosis and synergizes with immunotherapy in lung cancer.Signal Transduction and Targeted Therapy.(IF:39.3） Loss of lncRNA LINC01056 leads to sorafenib resistance in HCC.Molecular Cancer.(IF:37.3） Positive feedback regulation between glycolysis and histone lactylation drives oncogenesis in pancreatic ductal adenocarcinoma.Molecular Cancer.(IF:37.3） CIP2A induces PKM2 tetramer formation and oxidative phosphorylation in non-small cell lung cancer.Cell Discovery.(IF:33.5） IFRD1 promotes tumor cells “low-cost” survival under glutamine starvation via inhibiting histone H1.0 nucleophagy.Cell Discovery.(IF:33.5）